A detailed history of Northern Trust Corp transactions in Alpha Teknova, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 29,813 shares of TKNO stock, worth $176,194. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,813
Previous 30,430 2.03%
Holding current value
$176,194
Previous $41,000 251.22%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.2 - $5.17 $740 - $3,189
-617 Reduced 2.03%
29,813 $144,000
Q2 2024

Aug 14, 2024

SELL
$1.29 - $2.81 $577 - $1,258
-448 Reduced 1.45%
30,430 $41,000
Q1 2024

May 14, 2024

BUY
$2.41 - $3.88 $1,433 - $2,308
595 Added 1.96%
30,878 $81,000
Q4 2023

Feb 13, 2024

BUY
$1.85 - $3.73 $25,437 - $51,287
13,750 Added 83.17%
30,283 $112,000
Q3 2023

Nov 13, 2023

SELL
$1.66 - $3.83 $8,447 - $19,490
-5,089 Reduced 23.54%
16,533 $46,000
Q2 2023

Aug 11, 2023

SELL
$1.8 - $3.98 $69,112 - $152,816
-38,396 Reduced 63.97%
21,622 $57,000
Q1 2023

May 15, 2023

BUY
$2.74 - $6.25 $14,360 - $32,756
5,241 Added 9.57%
60,018 $177,000
Q4 2022

Feb 13, 2023

BUY
$3.23 - $5.64 $4,964 - $8,668
1,537 Added 2.89%
54,777 $308,000
Q3 2022

Nov 14, 2022

SELL
$3.34 - $9.2 $14,549 - $40,075
-4,356 Reduced 7.56%
53,240 $178,000
Q2 2022

Aug 12, 2022

SELL
$6.39 - $16.24 $43,682 - $111,016
-6,836 Reduced 10.61%
57,596 $484,000
Q1 2022

May 13, 2022

SELL
$12.79 - $21.64 $61,878 - $104,694
-4,838 Reduced 6.98%
64,432 $890,000
Q4 2021

Feb 08, 2022

BUY
$17.49 - $26.72 $141,126 - $215,603
8,069 Added 13.18%
69,270 $1.42 Million
Q3 2021

Nov 15, 2021

BUY
$17.47 - $27.49 $1.07 Million - $1.68 Million
61,201 New
61,201 $1.52 Million

Others Institutions Holding TKNO

About Alpha Teknova, Inc.


  • Ticker TKNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 28,080,500
  • Market Cap $166M
  • Description
  • Alpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; ...
More about TKNO
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.